D-Cysteine API Manufacturers & Suppliers

D-Cysteine (CAS Number 921-01-7) is a thiol-containing non-essential amino acid structurally related to the more commonly occurring L-cysteine. It is characterized by the presence of a sulfhydryl group, which contributes to its chemical reactivity, particularly its oxidation to form cystine via disulfide bond formation. This molecular transformation plays a role in redox biology and protein structure stabilization in broader biochemical contexts, although specific clinical indications or pharmacological uses of D-cysteine have not been established.

D-Cysteine belongs to the class of organic compounds known as cysteine and derivatives. These compounds include molecules derived through modification of the cysteine amino or carboxy groups or by substitution of hydrogen atoms within the glycine residue with heteroatoms. The stereochemical configuration of D-cysteine differentiates it from the L-enantiomer, with implications for its biological recognition and metabolism.

Currently, D-cysteine is categorized as experimental, with no approved therapeutic applications or formally recognized pharmacodynamics and mechanisms of action. As such, it is primarily utilized in research settings to explore biochemical pathways involving thiol chemistry, amino acid metabolism, and potential roles in enzyme function or redox balancing.

Key ADME parameters for D-cysteine are not well characterized in the literature. However, general metabolic understanding of amino acids suggests potential rapid absorption, distribution predominantly through systemic circulation, oxidation to cystine, and renal excretion of metabolites. Safety and toxicity data are limited; nevertheless, as with many amino acid derivatives, considerations include possible effects on sulfur metabolism and reactivity with cellular nucleophiles. No significant safety signals or toxicological profiles have been documented in clinical contexts due to its experimental status.

D-cysteine is not associated with any marketed pharmaceutical products or branded formulations. Its application remains within investigational and academic research domains rather than clinical or commercial pharmaceutical development.

From a sourcing perspective, quality considerations for D-cysteine as an active pharmaceutical ingredient (API) focus on stereochemical purity, control of residual impurities, and stability, given the susceptibility of thiol groups to oxidation. Reliable suppliers should provide documentation confirming enantiomeric excess and compliance with relevant pharmacopeial standards or established analytical methods. Appropriate storage and handling protocols must be maintained to preserve API integrity for research or formulation purposes.